Evaluation the pathogenicity and control of Penicillium citrinum isolates affecting the white fungus Agaricus bisporus
DOI:
https://doi.org/10.59658/jkas.v9i4.1064Keywords:
Agaricusbisporus, Penicillium citrinum, VEROXAbstract
Five isolates of Penicillium citrinumwere isolated from casing soils, copmpost and fruiting bodies of Agaricusbisporus from several culture stations in Iraq. According to the pathogenicity test, the highest percentage of inhibition was recorded for isolate P.citrinum(B1). The causal agent was molecularly diagnosed to the level of P. citrinumaccording to the nucleotide sequence analysis of the ITS genome region and it was recorded globally on the NCBI data base under the accission number ON738710.1.The effect of the hot aqueous extract of cloves and conocarpus, and the efficacy of the biocide VEROX on the production and phenotypic characteristics of the white edable fungus Agaricusbisporus was studied with the presence of the pathogenic fungus. The results showed that the treatment of the combination of plant extracts + biocide + pathogenic fungus led to the highest rate of growth inhibition of the pathogenic fungus, increasing number of fruiting bodies up to 435 compared to the control treatment of pathogenic fungus 140. The total yield of the same treatment was 16.398 kg compared to 3.343 kg in the control treatment, and the biological efficiency was recorded by 37.2% compared to 10.2% in the control treatment. In general, this combination led to an increase in production and an improvement in the qualitative characteristics of the fruiting bodies, as the average diameter of the cap was 40.6 mm and the stalk length was 37.3 mm compared to 27.8 mm and 23.5 mm in the control treatment, respectively.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Copyright (c) 2024 is the Author's article. Published by the Journal of Kerbala for Agricultural Sciences under a CC BY 4.0 license
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing Terms
All articles are published under a Creative Commons License and will be directed to the Creative Commons Attribution 4.0 International License (CC BY 4.0) That permits use, distribution, and reproduction in any medium, provided the original work is properly cited. This license also allows the work to be used for commercial purposes.
Use by both non-commercial and commercial users
This content is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, permitting use by both non-commercial and commercial users. Individual users may access, download, copy, display, and redistribute the articles to colleagues, as well as adapt, translate, and text- and data-mine the content, subject to the following conditions:
- The author's moral rights, including the right of attribution and the right to protect their work from derogatory treatment, are respected.
- Where content in the article is identified as belonging to a third party, users must ensure that any reuse complies with the copyright policies of the owner of that content.
- If the article content is reused for research or educational purposes, users should maintain a link to the appropriate bibliographic citation, including the DOI and a link to the published version on the journal's website.